Acusensus Limited Logo

Acusensus Limited

ACE.AX

(0.0)
Stock Price

0,88 AUD

-3.13% ROA

-4.21% ROE

-70.55x PER

Market Cap.

107.566.400,00 AUD

3.49% DER

0% Yield

-3.07% NPM

Acusensus Limited Stock Analysis

Acusensus Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Acusensus Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Acusensus Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Acusensus Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Acusensus Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Acusensus Limited Revenue
Year Revenue Growth
2018 46.000
2019 903.000 94.91%
2020 2.270.000 60.22%
2021 6.267.420 63.78%
2022 28.651.335 78.13%
2023 42.004.524 31.79%
2024 99.557.024 57.81%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Acusensus Limited Research and Development Expenses
Year Research and Development Expenses Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 187.231 100%
2023 449.845 58.38%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Acusensus Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 27.000
2019 182.000 85.16%
2020 780.000 76.67%
2021 3.411.560 77.14%
2022 2.941.719 -15.97%
2023 4.389.926 32.99%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Acusensus Limited EBITDA
Year EBITDA Growth
2018 0
2019 -97.000 100%
2020 -1.213.000 92%
2021 -2.885.760 57.97%
2022 4.379.880 165.89%
2023 5.697.120 23.12%
2024 7.404.160 23.06%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Acusensus Limited Gross Profit
Year Gross Profit Growth
2018 46.000
2019 884.000 94.8%
2020 1.104.000 19.93%
2021 -1.176.458 193.84%
2022 3.208.577 136.67%
2023 4.611.953 30.43%
2024 7.280.680 36.65%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Acusensus Limited Net Profit
Year Net Profit Growth
2018 -4.000
2019 -121.000 96.69%
2020 -1.255.000 90.36%
2021 -3.648.994 65.61%
2022 1.425.331 356.01%
2023 55.373 -2474.05%
2024 -5.126.280 101.08%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Acusensus Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Acusensus Limited Free Cashflow
Year Free Cashflow Growth
2018 -58.000
2019 -256.000 77.34%
2020 -2.156.000 88.13%
2021 -3.847.322 43.96%
2022 -2.275.748 -69.06%
2023 -1.117.996 -103.56%
2024 -1.069.731 -4.51%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Acusensus Limited Operating Cashflow
Year Operating Cashflow Growth
2018 -53.000
2019 -34.000 -55.88%
2020 -1.437.000 97.63%
2021 -1.000.953 -43.56%
2022 4.968.708 120.15%
2023 4.256.570 -16.73%
2024 3.125.464 -36.19%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Acusensus Limited Capital Expenditure
Year Capital Expenditure Growth
2018 5.000
2019 222.000 97.75%
2020 719.000 69.12%
2021 2.846.369 74.74%
2022 7.244.456 60.71%
2023 5.374.566 -34.79%
2024 4.195.195 -28.11%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Acusensus Limited Equity
Year Equity Growth
2020 2.652.000
2021 15.070.210 82.4%
2022 16.763.639 10.1%
2023 35.923.849 53.34%
2024 35.924.000 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Acusensus Limited Assets
Year Assets Growth
2020 3.415.000
2021 19.571.857 82.55%
2022 26.163.761 25.19%
2023 48.464.633 46.01%
2024 48.691.000 0.46%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Acusensus Limited Liabilities
Year Liabilities Growth
2020 714.000
2021 4.501.647 84.14%
2022 9.400.121 52.11%
2023 12.540.784 25.04%
2024 12.767.000 1.77%

Acusensus Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.39
Net Income per Share
-0.01
Price to Earning Ratio
-70.55x
Price To Sales Ratio
2.17x
POCF Ratio
30.04
PFCF Ratio
-27.29
Price to Book Ratio
2.99
EV to Sales
2.06
EV Over EBITDA
23.75
EV to Operating CashFlow
28.63
EV to FreeCashFlow
-25.98
Earnings Yield
-0.01
FreeCashFlow Yield
-0.04
Market Cap
0,11 Bil.
Enterprise Value
0,10 Bil.
Graham Number
0.28
Graham NetNet
0.13

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
-2.35
ROE
-0.04
Return On Assets
-0.03
Return On Capital Employed
-0.05
Net Income per EBT
1.52
EBT Per Ebit
0.5
Ebit per Revenue
-0.04
Effective Tax Rate
-0.52

Margins

Sales, General, & Administrative to Revenue
0.07
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.08
Operating Profit Margin
-0.04
Pretax Profit Margin
-0.02
Net Profit Margin
-0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.03
Free CashFlow per Share
-0.03
Capex to Operating CashFlow
2.1
Capex to Revenue
0.15
Capex to Depreciation
1.19
Return on Invested Capital
-0.08
Return on Tangible Assets
-0.03
Days Sales Outstanding
91.08
Days Payables Outstanding
13.93
Days of Inventory on Hand
10.07
Receivables Turnover
4.01
Payables Turnover
26.2
Inventory Turnover
36.23
Capex per Share
0.06

Balance Sheet

Cash per Share
0,15
Book Value per Share
0,28
Tangible Book Value per Share
0.28
Shareholders Equity per Share
0.28
Interest Debt per Share
0.01
Debt to Equity
0.03
Debt to Assets
0.03
Net Debt to EBITDA
-1.19
Current Ratio
3.15
Tangible Asset Value
0,04 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
35161999
Working Capital
0,02 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,00 Bil.
Average Inventory
1518047.5
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Acusensus Limited Dividends
Year Dividends Growth

Acusensus Limited Profile

About Acusensus Limited

Acusensus Limited, an intelligent traffic solutions (ITS) technology company, designs, develops, and commercializes technology focuses on the detection of distracted drivers in Australia. It offers s Acusensus Heads Up solution used to detect and capture prosecutable evidence of drivers illegally using mobile phones, whilst driving; Acusensus Heads-Up (Real Time Enforcement), a system for real-time enforcement of distracted driving and other offences; and Harmony enforcement camera system for use in developing economies. The company was incorporated in 2018 and is headquartered in Melbourne, Australia.

CEO
Mr. Alexander Jannink B.Comp
Employee
164
Address
333 Exhibition Street
Melbourne, 3000

Acusensus Limited Executives & BODs

Acusensus Limited Executives & BODs
# Name Age
1 Mr. Shaun Miller
Head of Customer Engagement
70
2 Mr. Matthew Higgins
Chief Operating Officer
70
3 Mr. Alexander Jannink B.Comp Sci, B.E., BCS, BEng Mechatr, M.B.A., MBA (
Co-Founder, MD, Chief Executive Officer & Executive Director
70
4 Ms. Anita Chow
Chief Financial Officer
70
5 Mr. Andrew Matthews
Head of Delivery
70
6 Mr. Christopher Kells B.E., BCS
Chief Technology Officer
70
7 Ms. Olivia Byron B.Com., L.L.B.
General Counsel & Company Secretary
70
8 Ms. Annmarie McMath
Head of Team Experience & Performance
70

Acusensus Limited Competitors

Antilles Gold Limited Logo
Antilles Gold Limited

AAU.AX

(1.2)
ADX Energy Ltd Logo
ADX Energy Ltd

ADX.AX

(1.0)
Astral Resources NL Logo
Astral Resources NL

AAR.AX

(1.0)